The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 09, 2021

Filed:

Mar. 19, 2019
Applicant:

Edwards Lifesciences Corporation, Irvine, CA (US);

Inventors:

David M. Taylor, Lake Forest, CA (US);

Tri D. Tran, Fountain Valley, CA (US);

Sean Chow, Tustin, CA (US);

David L. Hauser, Newport Beach, CA (US);

Pui Tong Ho, Ladera Ranch, CA (US);

Alexander H. Cooper, Costa Mesa, CA (US);

Assignee:
Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61F 2/24 (2006.01);
U.S. Cl.
CPC ...
A61F 2/2445 (2013.01); A61F 2/243 (2013.01); A61F 2/2409 (2013.01); A61F 2/2418 (2013.01); A61F 2/2433 (2013.01); A61F 2/2466 (2013.01); A61F 2/2448 (2013.01); A61F 2210/0014 (2013.01); A61F 2220/0016 (2013.01); A61F 2250/0014 (2013.01);
Abstract

Disclosed herein are devices for improving coaption of the mitral valve leaflets to reduce or eliminate mitral valve regurgitation. The devices may be used to perform mitral valve annuloplasty, or to serve as a docking station for a transcatheter prosthetic heart valve. The various embodiments of devices are configured for percutaneous and, in some cases, transvascular delivery. Delivery systems useful for routing the devices to the mitral valve are also disclosed, including catheters, balloons and/or mechanical expansion systems. The devices themselves include at least one tissue penetrating member. Methods of delivery include partially embedding the devices in the mitral valve annulus via at least one tissue penetrating member. Tissue penetrating members may be embedded into the tissue in a simultaneous or a nearly simultaneous fashion. Upon embedding, the devices employ various expansion and/or contraction features to adjust the mitral valve diameter. Adjustments may continue until the leaflets fully coapt and the problem of mitral regurgitation is reduced or eliminated.


Find Patent Forward Citations

Loading…